Atomistry » Bromine » PDB 3r3x-3tv4 » 3tv4
Atomistry »
  Bromine »
    PDB 3r3x-3tv4 »
      3tv4 »

Bromine in PDB 3tv4: Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor

Enzymatic activity of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor

All present enzymatic activity of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor:
2.7.11.1;

Protein crystallography data

The structure of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor, PDB code: 3tv4 was solved by W.C.Voegtli, L.T.Selby, W.-I.Wu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 30.00 / 3.40
Space group P 41 21 2
Cell size a, b, c (Å), α, β, γ (°) 107.966, 107.966, 153.142, 90.00, 90.00, 90.00
R / Rfree (%) 24.1 / 30.7

Other elements in 3tv4:

The structure of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor also contains other interesting chemical elements:

Fluorine (F) 4 atoms

Bromine Binding Sites:

The binding sites of Bromine atom in the Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor (pdb code 3tv4). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total 2 binding sites of Bromine where determined in the Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor, PDB code: 3tv4:
Jump to Bromine binding site number: 1; 2;

Bromine binding site 1 out of 2 in 3tv4

Go back to Bromine Binding Sites List in 3tv4
Bromine binding site 1 out of 2 in the Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br1

b:43.5
occ:0.25
BR8 A:TV41 0.0 43.5 0.2
C3 A:TV41 1.9 43.3 1.0
C2 A:TV41 2.9 43.3 1.0
C4 A:TV41 2.9 42.5 1.0
N7 A:TV41 3.1 43.0 1.0
CH2 A:TRP531 3.9 53.6 1.0
CZ3 A:TRP531 3.9 52.7 1.0
N1 A:TV41 4.2 43.5 1.0
C5 A:TV41 4.2 41.5 1.0
CE2 A:PHE583 4.3 44.1 1.0
CG2 A:ILE463 4.4 75.8 1.0
C6 A:TV41 4.6 42.9 1.0
CB A:ILE463 4.7 75.9 1.0
CZ2 A:TRP531 4.8 53.2 1.0
CG1 A:ILE463 4.8 75.8 1.0
CE3 A:TRP531 4.9 52.2 1.0

Bromine binding site 2 out of 2 in 3tv4

Go back to Bromine Binding Sites List in 3tv4
Bromine binding site 2 out of 2 in the Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 2 of Human B-Raf Kinase Domain in Complex with An Bromopyridine Benzamide Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Br1

b:48.2
occ:0.25
BR8 B:TV41 0.0 48.2 0.2
C3 B:TV41 1.9 47.1 1.0
C4 B:TV41 2.9 46.9 1.0
C2 B:TV41 2.9 47.5 1.0
N7 B:TV41 3.1 48.2 1.0
CH2 B:TRP531 3.3 48.0 1.0
CZ3 B:TRP531 3.4 47.0 1.0
N1 B:TV41 4.2 48.1 1.0
C5 B:TV41 4.2 46.5 1.0
CZ2 B:TRP531 4.3 47.5 1.0
CE3 B:TRP531 4.4 46.2 1.0
CE2 B:PHE583 4.5 49.6 1.0
CG1 B:ILE463 4.6 65.4 1.0
C6 B:TV41 4.6 47.6 1.0
CB B:ILE463 5.0 65.7 1.0

Reference:

S.Wenglowsky, L.Ren, K.A.Ahrendt, E.R.Laird, I.Aliagas, B.Alicke, A.J.Buckmelter, E.F.Choo, V.Dinkel, B.Feng, S.L.Gloor, S.E.Gould, S.Gross, J.Gunzner-Toste, J.D.Hansen, G.Hatzivassiliou, B.Liu, K.Malesky, S.Mathieu, B.Newhouse, N.J.Raddatz, Y.Ran, S.Rana, N.Randolph, T.Risom, J.Rudolph, S.Savage, L.T.Selby, M.Shrag, K.Song, H.L.Sturgis, W.C.Voegtli, Z.Wen, B.S.Willis, R.D.Woessner, W.I.Wu, W.B.Young, J.Grina. Pyrazolopyridine Inhibitors of B-Raf(V600E). Part 1: the Development of Selective, Orally Bioavailable, and Efficacious Inhibitors. Acs Med Chem Lett V. 2 342 2011.
ISSN: ISSN 1948-5875
PubMed: 24900315
DOI: 10.1021/ML200025Q
Page generated: Mon Jul 7 05:58:16 2025

Last articles

Na in 9K73
Na in 9K7B
Na in 9JLN
Na in 9JIU
Na in 9JDA
Na in 9JFF
Na in 9JFB
Na in 9JD9
Na in 9JD5
Na in 9JD4
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy